Anti-viral azide containing compounds
AssigneeLife Technologies Corporation
InventorsBrian Agnew, Upinder Singh, Scott Grecian
Life of this patent
Estimating the term…
Loading patent…
AssigneeLife Technologies Corporation
InventorsBrian Agnew, Upinder Singh, Scott Grecian
Estimating the term…
Methods of using azide-modified biomolecules, such as fatty acids, carbohydrates and lipids, to treat a plant, an insect or an animal infected with a virus or to inhibit infectivity of a virus, such as the human immunodeficiency virus, are provided. Also provided are methods of labeling a virus, such as human immunodeficiency virus, with an azide-modified biomolecule, such as a fatty acid, a carbohydrate, or an isoprenoid lipid. Also, provided are methods of tracking a virus in vivo, with an azide-modified biomolecule, such as a fatty acid, a carbohydrate, or an isoprenoid lipid. The azide-modified biomolecules may be combined with a pharmaceutically acceptable excipient to produce a pharmaceutical composition, optionally containing another anti-viral agent and/or a delivery agent, such as a liposome.
A method of tracking a virus in vivo comprising the steps of
Dependencies are inferred from the claim text.